Previous studies have proposed factors potentially affecting the prognosis of patients with CML-CP, such as high WBC count, low hemoglobin concentration, high percentage of blood basophils, high ELTS risk score, high-risk ACAs, and possibly some BCR::ABL transcript types (31–33). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.